Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	Virtual and Standard Colonoscopy Both Accurate Denosumab May Help Prevent Bone Loss Past Highlights



Results: 31 -40 of 97 Show results per page	View Search Criteria \| Help With Results

Last Modified: 10/29/2007 First Published: 7/1/2002


31.		Phase II Study of Alemtuzumab, Low-Dose Total Body Irradiation, and Fludarabine Followed By HLA Class I Mismatched Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematologic Malignancies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				Under 75				NCI				FHCRC-1591.00 NCI-H02-0089, NCT00040846

Last Modified: 10/1/2008 First Published: 9/1/2002


32.		Phase II Study of a Reduced-Intensity Preparative Regimen With Allogeneic Bone Marrow Transplantation in Patients With Myelodysplastic Syndromes

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 to 70				NCI				ECOG-E1902 NCT00045305, E1902

Last Modified: 1/18/2008 First Published: 10/1/2002


33.		Phase II Pilot Study of Induction Chemotherapy Followed By Allogeneic/Syngeneic Peripheral Blood Stem Cell Transplantation in Patients With High-Risk, Recurrent Pediatric Sarcoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				4 to 35				NCI				NCI-02-C-0259H NCT00047372

Last Modified: 4/12/2007 First Published: 2/21/2003


34.		Phase II Study of Allogeneic Stem Cell Transplantation in Patients With Metastatic Renal Cell Carcinoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 to 65				Other				FRE-FNCLCC-GETUG-11/0105 EU-20234, NCT00056095

First Published: 4/23/2003


35.		Phase II Study of Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Fludarabine-Refractory Chronic Lymphocytic Leukemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				21 and over				NCI				FHCRC-1711.00 NCT00060424

Last Modified: 10/9/2008 First Published: 9/24/2003


36.		Phase II Study of Cyclosporine in Patients With Recurrent or Refractory Angioimmunoblastic T-Cell Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				18 and over				NCI				ECOG-2402 NCT00070291, E2402

Last Modified: 8/8/2008 First Published: 1/23/2004


37.		Pilot Study of Donor Th2 Cells Generated In Vitro By Sirolimus Treatment With or Without Oral Sirolimus Versus Oral Sirolimus Alone For Prevention Of Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Hematologic Malignancies

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Supportive care, Treatment				Active				18 to 75				NCI				NCI-04-C-0055 NCT00077480


38.		Cord Blood Transplantation for Sickle Cell Anemia and Thalassemia

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Tissue collection/Repository, Treatment				Active				3 to 14				NHLBI				141 U01 HL61877, NCT00029380

Last Modified: 6/10/2008 First Published: 5/28/2004


39.		Phase II Study of Umbilical Cord Blood as a Source of Hematopoietic Stem Cells for Transplantation in Children With Malignant or Non-Malignant Diseases

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				21 and under				Other				PSCI-2003-232 NCT00084695

Last Modified: 4/18/2008 First Published: 2/18/2005


40.		Phase II Study of Nonmyeloablative Conditioning Comprising Fludarabine and Low-Dose Total-Body Irradiation Followed By Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Fludarabine-Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Active				Any age				NCI, Other				FHCRC-1840.00 NCT00104858

Select All on One Page


					< Previous 1 2 3 4 5 6 7 Next >

| | | | | | | |

A Service of the National Cancer Institute